Arkolith/Insider Trading/BLTE/Form 4

Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Apr 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$166K
Net Open-Market Flow
-$166K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2026Sell(S)64$163.49$10K13K
Apr 21, 2026Sell(S)78$164.60$13K13K
Apr 21, 2026Sell(S)332$165.49$55K12K
Apr 21, 2026Sell(S)312$166.49$52K12K
Apr 21, 2026Sell(S)214$167.34$36K12K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-170443) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML